NEWS
Holiferm acquires Organica to commercialise biosurfactants
UK-based biosurfactant manufacturer Holiferm has acquired Organica UK, a specialist producer and supplier of biodegradable and non-hazardous household laundry and cleaning products. Strengthened by a continued
partnership with investors Sadorp, the transaction creates a combined business spanning ingredient development, advanced applications, product manufacturing, and commercialisation. The combination brings together
Holiferm’s biosurfactant innovation and manufacturing with Organica’s formulation and finished-product capability, By coming together, Holiferm and
Organica are demonstrating renewed strength for the sector, boosting the global availability of sustainable cost effective and high-performance
alternatives to fossil-based chemistry.
The deal blends Organica’s
formulation of biodegradable and non-hazardous cleaning products with Holiferm’s nature-derived biosurfactant technology to create an end-to-end platform that gives global customers access to science and ingredient innovation, and product development and manufacturing. The two businesses have worked
together since 2023 and will continue to operate from adjacent sites, giving
them room to expand production, accelerate joint innovation, and pursue new growth opportunities together. Charles Dimmler (pictured, right),
CEO of Holiferm, said: “This strategic combination accelerates our path to profitability and expands our ability to serve customers and partners with real applications development capability. It shows the link between science, engineering and product development all the way through to store shelves.” Chris Arthur (pictured, left),
owner of Organica UK, added: “Joining forces with Holiferm allows us to combine our heritage in high-quality formulation with their groundbreaking biomanufacturing technology. Specific transaction terms have
not been disclosed. Symrise offloads terpenes business to private equity
Symrise has sold AmeriTerpenes, its terpene ingredients business, to Munich, Germany-based private equity investor Mutares for an undisclosed sum. AmeriTerpenes, a producer of
renewable terpene ingredients, serves customers across fragrance, flavour and industrial applications from its US-based manufacturing sites in Jacksonville, Florida and Colonels Island, Georgia. The signing and closing
of the transaction took place simultaneously. Both parties to the transaction have agreed to keep financial details relating to the transaction confidential. The transaction is expected to result in a non-cash disposal
loss amounting to a mid-double- digit million-euro impact, which will reflect in Symrise’s annual financial statements 2026. Symrise said the divestiture
will enable it to further sharpen its portfolio and increase management focus on its core growth platforms. Dr Jean-Yves Parisot, CEO of
Symrise, said: “This transaction gives a good example of how we are actively shaping Symrise for the future with continued portfolio management: AmeriTerpenes is a strong business with excellent people, longstanding customer relationships and differentiated manufacturing capabilities. “We are pleased that, with Mutares, we have found an
experienced owner that brings a strong operational track record in corporate carve-outs and is well- suited to support AmeriTerpenes into its future,” he added. “We also look forward to
continuing our partnership with AmeriTerpenes and Mutares as its new owner through strategic agreements entered into as part of the transaction.”
9
Unilever, Galaxy Surfactants sign
R&D charter Unilever and Galaxy Surfactants have signed a ‘Partnership Growth Charter’ designed to accelerate the development of next-generation surfactant technologies and new chemistries. The charter between the British
and Indian firms marks a milestone in a 45-year partnership and begins a new phase of scientific advances to be translated faster into superior products and consumer experiences. Unilever says Galaxy’s
surfactant science has been critical in the performance-enhancing reformulations of its Dove body wash. Galaxy’s powder surfactant
capabilities have meanwhile helped enable innovative powder-to- liquid handwash formats, reducing transportation and packaging footprint while offering a convenient at-home dilution experience for consumers. The charter focuses sets out
three priorities. First, innovation and product superiority by accelerating new chemistries that can deliver differentiated product performance and superior consumer experience. Second, future supply resilience
and growth capacity by exploring bio-based alternatives and lower- carbon technologies, investing in strategic capacity and long-term planning to strengthen resilience and support future growth. Thirdly, competitiveness through
value-chain innovation by sustaining market-competitive costs through closer collaboration and value-chain innovation. Unilever chief procurement
officer Shailendra Sadera said: “The signing of the Partnership Growth Charter demonstrates how we partner to win by building strategic, long-term relationships that unlock collaborative innovation, transformation and value for both Unilever and our partners,” he added.
Ashland appoints financial advisers as it considers sale
Ashland is exploring a potential sale after attracting takeover interest from several private equity companies. Bloomberg News reported
the ingredients maker as having appointed Citigroup and Lazard as it considers approaches from Advent, Apollo Global Management, Carlyle Group and Standard Industries.
www.personalcaremagazine.com According to the report, the New
York Stock Exchange-listed firm has come under pressure from activist investors who argued the company was undervalued. Ashland’s decision to explore a
sale comes after months of pressure from activist investor Ancora Alternatives, which disclosed a stake
in the speciality chemicals company in June. Ancora argued a transaction could
boost Ashland’s share price by at least 30% and estimated the stock could be worth at least $76 a share in a takeover. Since the beginning of 2026,
Ashland’s shares have grown by 30%. October 2026 PERSONAL CARE MAGAZINE
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132
